SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-23-134747
Filing Date
2023-05-04
Accepted
2023-05-03 21:51:26
Documents
1
Effectiveness Date
2023-05-04

Document Format Files

Seq Description Document Type Size
1 S-8 POS d171989ds8pos.htm S-8 POS 26113
  Complete submission text file 0001193125-23-134747.txt   27335
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-270566 | Film No.: 23886153
SIC: 2836 Biological Products, (No Diagnostic Substances)